Sarepta Therapeutics (AB3A) Q2 2025 Earnings Report
CH:AB3A Q2 2025 EPS Results
- Actual EPS
- CHF 1.56
- Consensus EPS
- CHF 0.69
- Beat/Miss
- Beat by +CHF 0.87
- One Year Ago EPS
- CHF 0.06
CH:AB3A Q2 2025 Revenue Results
- Actual Revenue
- CHF 504.03M
- Expected Revenue
- CHF 437.69M
- Beat/Miss
- Beat by +CHF 66.34M
- YoY Revenue Growth
- +68.38%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/06/2025
- Time
- After Close
- Conference Call
- Wednesday, August 6, 2025
CH:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.06- | -1.48 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 0.18-0.04 | 1.56 | -102.65% (-1.60) | |
| May 06, 2026 | 2026 (Q1) | 0.812.38 | -3.79 | 162.61% (+6.17) | |
| Feb 25, 2026 | 2025 (Q4) | -0.99-3.24 | 1.24 | -362.00% (-4.48) | |
| Nov 03, 2025 | 2025 (Q3) | -0.60-1.48 | 0.28 | -629.41% (-1.77) | |
| Aug 06, 2025 | 2025 (Q2) | 0.691.56 | 0.06 | 2600.00% (+1.50) | |
| May 06, 2025 | 2025 (Q1) | -2.65-3.79 | 0.31 | -1343.24% (-4.10) | |
| Feb 26, 2025 | 2024 (Q4) | 1.551.24 | 0.39 | 219.15% (+0.85) | |
| Nov 06, 2024 | 2024 (Q3) | -0.060.28 | -0.38 | 173.91% (+0.66) | |
| Aug 07, 2024 | 2024 (Q2) | -0.110.06 | -0.22 | 125.93% (+0.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
